Subtopic Deep Dive

Keratin Gene Mutations in Skin Disorders
Research Guide

What is Keratin Gene Mutations in Skin Disorders?

Keratin gene mutations in skin disorders refer to pathogenic variants in KRT1-KRT17 genes that disrupt intermediate filament assembly, causing inherited conditions like epidermolysis bullosa simplex, pachyonychia congenita, and ichthyoses.

Mutations in keratin genes lead to protein misfolding and filament destabilization in epithelial cells (Moll et al., 2008; 1420 citations). These changes cause skin fragility and hyperkeratosis through genotype-phenotype correlations (Irvine and McLean, 1999; 397 citations). Over 70 intermediate filament genes, including keratins, link to human diseases (Szeverényi et al., 2007; 370 citations).

Curated Papers

Key Challenges

Why It Matters

Keratin mutations explain mechanisms of skin fragility in rare disorders, enabling precision diagnostics and therapies like gene editing (Lane and McLean, 2004; 234 citations). The Human Intermediate Filament Database supports mutation cataloging for clinical genotyping (Szeverényi et al., 2007). Studies on KRT14 knockouts reveal basal keratinocyte roles in blistering diseases (Rugg et al., 1994; 177 citations). Insights guide treatments for pachyonychia congenita and ichthyoses (Smith, 2003; 164 citations; Vahlquist et al., 2017; 174 citations).

Key Research Challenges

Subtle Phenotype-Genotype Correlation

Keratin mutations show complex correlations where similar variants yield variable phenotypes across patients (Irvine and McLean, 1999; 397 citations). Environmental factors and modifier genes complicate predictions. Functional assays are needed to classify pathogenicity (Omary et al., 2004; 474 citations).

Filament Destabilization Mechanisms

Mutations cause protein aggregation and cytoskeletal collapse, but exact biophysical pathways remain unclear (Moll et al., 2008; 1420 citations). In vitro filament assembly models struggle with disease-specific dynamics. Advanced imaging tracks misfolding in live cells (Lane and McLean, 2004; 234 citations).

Therapeutic Gene Editing Barriers

CRISPR strategies face delivery challenges to keratinocytes and off-target risks in stratified epithelia. Patient-derived organoids show variable editing efficiency (Chamcheu et al., 2010; 188 citations). Clinical translation lags due to mosaicism in germline mutations.

Essential Papers

The human keratins: biology and pathology

Roland Moll, Markus Divo, Lutz Langbein · 2008 · Histochemistry and Cell Biology · 1.4K citations

Intermediate Filament Proteins and Their Associated Diseases

M. Bishr Omary, Pierre A. Coulombe, W.H. Irwin McLean · 2004 · New England Journal of Medicine · 474 citations

he cytoskeleton consists of three abundant families of fibrillary proteins: microfilaments, microtubules, and intermediate filaments. 1,2ntermediate filament proteins derive their name from their d...

Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation

Alan D. Irvine, W.H. Irwin McLean · 1999 · British Journal of Dermatology · 397 citations

Keratins are obligate heterodimer proteins that form the intermediate filament cytoskeleton of all epithelial cells. Keratins are tissue and differentiation specific and are expressed in pairs of t...

Keratin 6, 16 and 17—Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis

Xiaowei Zhang, Meimei Yin, Ling‐juan Zhang · 2019 · Cells · 389 citations

Located at the skin surface, keratinocytes (KCs) are constantly exposed to external stimuli and are the first responders to invading pathogens and injury. Upon skin injury, activated KCs secrete an...

The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases

Ildikó Szeverényi, Andrew Cassidy, Cheuk Wang Chung et al. · 2007 · Human Mutation · 370 citations

We describe a revised and expanded database on human intermediate filament proteins, a major component of the eukaryotic cytoskeleton. The family of 70 intermediate filament genes (including those ...

Keratins and skin disorders

EB Lane, W.H. Irwin McLean · 2004 · The Journal of Pathology · 234 citations

Abstract The association of keratin mutations with genetic skin fragility disorders is now one of the best‐established examples of cytoskeleton disorders. It has served as a paradigm for many other...

Keratin gene mutations in disorders of human skin and its appendages

Jean Christopher Chamcheu, Imtiaz A. Siddiqui, Deeba N. Syed et al. · 2010 · Archives of Biochemistry and Biophysics · 188 citations

Reading Guide

Foundational Papers

Start with Moll et al. (2008; 1420 citations) for keratin biology overview, then Omary et al. (2004; 474 citations) for filament diseases, and Irvine and McLean (1999; 397 citations) for mutation spectra.

Recent Advances

Study Zhang et al. (2019; 389 citations) on KRT6/16/17 alarmins, Vahlquist et al. (2017; 174 citations) on ichthyoses updates, and Chamcheu et al. (2010; 188 citations) for appendage disorders.

Core Methods

Genotyping via sequencing; filament assembly in transfected cells; phenotype correlation from patient registries; biophysical modeling of destabilization (Rugg et al., 1994; Lane and McLean, 2004).

How PapersFlow Helps You Research Keratin Gene Mutations in Skin Disorders

Discover & Search

Research Agent uses searchPapers('keratin mutations epidermolysis bullosa') to retrieve 50+ papers like Moll et al. (2008), then citationGraph reveals W.H. Irwin McLean clusters (e.g., Irvine and McLean, 1999). findSimilarPapers on 'The human keratins: biology and pathology' uncovers Lane and McLean (2004), while exaSearch scans preprints for KRT17 updates.

Analyze & Verify

Analysis Agent applies readPaperContent on Szeverényi et al. (2007) to extract mutation databases, then verifyResponse with CoVe cross-checks claims against Omary et al. (2004). runPythonAnalysis processes genotype-phenotype data with pandas for correlation stats, graded by GRADE for evidence strength in filament diseases.

Synthesize & Write

Synthesis Agent detects gaps in phenotype correlations from Irvine and McLean (1999), flags contradictions in KRT6/16 roles (Zhang et al., 2019). Writing Agent uses latexEditText for manuscript sections, latexSyncCitations integrates 20+ refs like Rugg et al. (1994), and latexCompile previews; exportMermaid diagrams keratin filament networks.

Use Cases

"Analyze mutation frequencies in KRT14 for epidermolysis bullosa simplex from database papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas count mutations from Szeverényi et al., 2007 CSV extracts) → matplotlib frequency plots and statistical p-values.

"Write review section on keratin mutation therapies with citations"

Synthesis Agent → gap detection → Writing Agent → latexEditText('therapeutics') → latexSyncCitations(Omary et al., 2004; Chamcheu et al., 2010) → latexCompile → PDF with formatted genotype-phenotype table.

"Find code for keratin filament simulation models"

Research Agent → paperExtractUrls('keratin modeling') → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for filament dynamics from papers citing Lane and McLean (2004).

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'KRT1-KRT17 mutations', structures report with McLean-cited clusters (e.g., 1999, 2004). DeepScan applies 7-step CoVe to verify Zhang et al. (2019) alarmin claims against Moll et al. (2008). Theorizer generates hypotheses on KRT17 editing from Rugg et al. (1994) knockout data.

Try Doxa for Keratin Gene Mutations in Skin Disorders Research

Frequently Asked Questions

What defines keratin gene mutations in skin disorders?

Pathogenic variants in KRT1-KRT17 disrupt heterodimer filaments, causing fragility in epidermolysis bullosa simplex and pachyonychia (Irvine and McLean, 1999).

What are key methods for studying these mutations?

Sequencing identifies variants; functional assays test filament assembly; databases like Szeverényi et al. (2007) catalog 70+ genes (Omary et al., 2004).

What are seminal papers on keratin diseases?

Moll et al. (2008; 1420 citations) covers biology/pathology; Irvine and McLean (1999; 397 citations) details phenotype correlations; Lane and McLean (2004; 234 citations) links to fragility disorders.

What open problems persist?

Subtle genotype-phenotype links need modifiers identified; therapeutic delivery to skin barriers unsolved; mosaicism complicates editing (Chamcheu et al., 2010).